Chronic Disease Management and MBS deferred to 1 July 2025

September 26, 2024

On 25 September the Department of Health and Aged Care announced the commencement date for Chronic Conditions Management MBS item changes have been deferred to 1 July 2025.

The additional time will support all practices and providers, including GPs and allied health providers, to be ready for the changes to these important services. Previously, these changes were due to come into effect from 1 November 2024. 

Steps your practice can take to prepare

Here are some ideas you might like to consider starting to prepare your practice team for Chronic Conditions Management and MyMedicare patient registration:

  1. Discuss what these changes mean with your practice team and identify any activities or processes you need to review or update (e.g. incorporating MyMedicare registration in your workflows for chronic disease/conditions management).
  2. Register your practice for MyMedicare if you have not done so already.
  3. Engage your patients to encourage them to register with MyMedicare, particularly those with a chronic condition or existing care plan:

The MyMedicare communication resources for General Practice includes social media tiles, videos, brochures and posters. 

SEMPHN will continue to keep you updated with more information about these changes as they are released. Please contact us your Provider Support Officer for more information and support.

Learn more about MyMedicare

Latest news

August 19, 2026
Every patient consultation provides an opportunity to review a patient’s immunisation history and vaccination status, while talking through any questions or concerns they may have about vaccination.
August 17, 2026
The purpose of this activity is to ensure that patients with both a mental health and chronic disease diagnosis are identified and proactively offered guidance and support to register with MyMedicare, improving care coordination and access to relevant incentives and services.
August 12, 2026
Recent vaccine supply and distribution issues have caused temporary vaccine shortages of the Capvaxive ® (pneumococcal) vaccine.